Growth and growth hormone secretion after treatment for childhood non- Hodgkin's lymphoma

Medical and Pediatric Oncology

Volumn 28, Issue 1, 1997, Pages 27-34

  Samuelsson, B O ^a   Marky, I ^a   Rosberg, S ^a   Albertsson Wikland, K ^a  

^a Department of Pediatrics   (Sweden)

Author keywords

chemotherapy; growth; growth hormone; NHL

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; GROWTH HORMONE; HYDROXYUREA; IFOSFAMIDE; LOMUSTINE; METHOTREXATE; PREDNISOLONE; TENIPOSIDE; TIOGUANINE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BODY HEIGHT; BONE GROWTH; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GROWTH HORMONE RELEASE; GROWTH RETARDATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NONHODGKIN LYMPHOMA; ONSET AGE; PRIORITY JOURNAL; STEROID THERAPY;

ADOLESCENT; ADULT; AGE OF ONSET; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; GROWTH; GROWTH HORMONE; HUMANS; LONGITUDINAL STUDIES; LYMPHOMA, NON-HODGKIN; MALE; SECRETORY RATE;

EID: 0031021315     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199701)28:1<27::AID-MPO6>3.0.CO;2-V     Document Type: Article

References (80)